Several medications effectively treat OCD, with a specific class of antidepressants called SSRIs being the most widely prescribed. Five medications currently have FDA approval for OCD, and about 60% of patients see their symptoms drop by 40% to 50% or more within 10 to 12 weeks of starting treatment. Medication works best when combined with a form of therapy called exposure and response prevention (ERP), but it can also produce meaningful improvement on its own.
FDA-Approved Medications for OCD
Four SSRIs and one older tricyclic antidepressant carry FDA approval specifically for OCD:
- Fluoxetine (Prozac) for adults and children 7 and older
- Fluvoxamine (Luvox) for adults and children 8 and older
- Sertraline (Zoloft) for adults and children 6 and older
- Paroxetine (Paxil) for adults only
- Clomipramine (Anafranil) for adults and children 10 and older
SSRIs are the first choice for most people because they tend to cause fewer side effects than clomipramine. Clomipramine was actually the first medication shown to work for OCD, and it remains highly effective, but its side effect profile (dry mouth, constipation, drowsiness, weight gain) makes it a second-line option for many prescribers. Some people who don’t respond to SSRIs do well on clomipramine, so it stays in the toolkit.
How These Medications Work
OCD involves overactive signaling in a brain circuit that loops between the cortex (where thoughts form), the striatum (which filters those thoughts), and the thalamus (which relays information back up). In people with OCD, this loop gets stuck, cycling the same distressing thoughts and urges over and over. SSRIs increase the availability of serotonin, which helps calm this circuit and reduce the intensity of obsessions and compulsions.
Serotonin isn’t the whole story. Research shows that glutamate, the brain’s main excitatory chemical, is also dysregulated in OCD. Brain scans have found elevated glutamate-related compounds in key parts of this circuit, and those levels normalize when SSRI treatment works. One explanation is that SSRIs reduce serotonin-triggered glutamate release, essentially turning down the volume on an overexcited loop. This is part of why OCD requires a different treatment approach than depression, even though both conditions use similar medications.
OCD Requires Higher Doses and More Patience
One of the most important things to understand about OCD medication is that it works differently than the same drugs used for depression. OCD typically requires higher doses, and it takes longer to kick in. A standard depression trial might show results in four to six weeks. OCD medication needs eight to 12 weeks, with at least six of those weeks at a moderate to high dose, before you and your prescriber can judge whether it’s working.
According to Stanford Medicine, noticeable benefit usually appears after six weeks but can take eight weeks to begin. Improvement often continues well beyond the 12-week mark, so even if progress feels slow at first, that doesn’t mean the medication has failed. The International OCD Foundation emphasizes that progress “occurs at a slow rate” and can take several weeks to become apparent. Stopping too early or staying at too low a dose are two of the most common reasons people conclude a medication didn’t work when it might have.
What “Working” Actually Looks Like
OCD medication doesn’t eliminate obsessive thoughts entirely. A realistic expectation is a 40% to 50% reduction in symptom severity, which in practice means the thoughts still show up but carry less urgency, take up less of your day, and are easier to resist. About 60% of patients hit this threshold within 10 to 12 weeks on an adequate dose.
For context, a meta-analysis looking at youth with OCD found that SSRIs alone produced remission in about 47% of patients, while cognitive behavioral therapy alone achieved remission in 57%. Combining the two approaches generally produces the best outcomes. If medication brings your symptoms down to a manageable level, adding ERP therapy can push you further toward recovery.
When the First Medication Doesn’t Work
Not everyone responds to the first SSRI they try. If one doesn’t produce meaningful improvement after a full 10 to 12 week trial at the maximum tolerable dose, the usual next step is switching to a different SSRI. Each one has a slightly different chemical profile, and it’s common for someone to respond well to one but not another.
If two or three SSRIs haven’t worked, prescribers may try clomipramine or add a second medication on top of the SSRI. Low doses of certain antipsychotic medications are sometimes used as add-on treatments. This strategy targets dopamine, another brain chemical implicated in OCD’s circuitry. These augmentation approaches are reserved for treatment-resistant cases because they introduce additional side effects, but they can make a real difference for people who haven’t responded to SSRIs alone.
Researchers are also exploring medications that target glutamate directly, based on the evidence that this neurotransmitter plays a significant role in OCD. While these aren’t standard treatments yet, the science behind them is promising and reflects a growing understanding that OCD involves more than just serotonin.
How Long You’ll Stay on Medication
Once your symptoms are well controlled, guidelines from the American Psychiatric Association recommend continuing medication for one to two years before considering a taper. This isn’t arbitrary. OCD has a high relapse rate when medication is stopped too soon, and a longer period of stability makes relapse less likely.
When the time comes to reduce your dose, the recommended approach is gradual: cutting by 10% to 25% every one to two months while monitoring for returning symptoms. Some people eventually come off medication completely, especially if they’ve also done ERP therapy and have strong coping strategies in place. Others stay on a maintenance dose long-term because the benefits outweigh the downsides. Neither path is a failure.
Medications for Children and Teens
Three of the five FDA-approved OCD medications are cleared for children: sertraline (age 6 and up), fluoxetine (age 7 and up), and fluvoxamine (age 8 and up). Clomipramine is approved for children 10 and older. Fluvoxamine’s pediatric approval was based on a 10-week controlled study of 120 outpatients ages 8 to 17, and notably, it is not approved for any other pediatric condition besides OCD.
For children, most treatment guidelines recommend starting with ERP therapy before adding medication, since many kids respond well to therapy alone. When medication is needed, the same principles apply: start low, increase gradually, and allow a full 8 to 12 weeks before judging effectiveness. Pediatric dosing is generally lower than adult dosing, and close monitoring during the first few months is standard practice.